Ineffectual corporate management has given a great gift to programmers,
system administrators, and CIOs - endless corporate accounting scandals. Our
federal government has not missed this scandalous behavior as they have
passed an extraordinarily strong, far-reaching law to contend with financial
Officially it's called the Public Company Accounting Reform and Investor
Protection Act, but it's more commonly know as the Sarbanes-Oxley Act. The
Sarbanes-Oxley Act is a very special piece of legislation designed to keep
corporate managers honest. The Act awards dishonesty with a 10- or 20-year
prison sentence for CEOs and CFOs. In addition, it has a provision for taking
any and all ill-gotten gains from the dishonest executive. There are
approximately 14,000 publicly traded companies in the United States, with
just about 7,400 of them traded on the New York, the ... (more)
JM: What does Viador do?
DL: Viador is a business intelligence tools ISV.
JM: What type of Business Intelligence tools?
DL: We provide reporting and OLAP analysis tools for customers that need to
do reporting and analyze their data such as financial analysis.
JM: What customer base do you have; who uses your tools?
DL: Our customer base is quite broad. We have Fortune 500 companies like
Citibank, Verizon, JP Morgan; and we also have medium-sized shops like
Spectra Marketing, which provides a hosted solution (ASP). Viador also has a
very strong presence in China. We are one of the lar... (more)
Jack Martin, editor-in-chief of WebSphere Developer's Journal, recently sat
down to talk with Jocelyne A. Attal about IBM's plans for the future of
WSDJ: What do you do at IBM?
Jocelyne: I'm the vice president for marketing for the WebSphere brand. Which
means a lot of things. I have a wonderful team that covers a very large scope
of work for WebSphere. We work on strategy and design for the next version of
WebSphere, making sure it has what customers and developers need and want. We
are very focused on customer needs. Based on input from technical experts
like Danny S... (more)
Jack Martin, editor-in-chief of WSDJ, recently spoke with Dr. Sharon Nunes,
IBM's director of Life Sciences Solution development, about how
pharmaceutical companies are handling the rapid growth of information in drug
WSDJ: How did IBM get involved in the pharmaceutical industries and what type
of problem were you trying to solve?
Sharon Nunes: In the mid '90s, IBM Research was collaborating on a few joint
projects with pharmaceutical companies in the area of drug design and in the
area of creating algorithms for pattern discovery and pattern matching. These
After reading Jim Martin's closing piece last month I wondered if we were
living on the same planet. He envisions a huge upturn in tech spending - a
return to the good old days. I see massive consolidation, with the weakest
players going out of business and the companies with good, serviceable
products either just getting by or being acquired.
The handwriting is on the wall. All one must do to see the future is look at
what is happening to the companies who actually buy enterprise technology.
For example, Burger King and McDonald's have rolled prices back to the 1970s
for their ... (more)